VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: betty moyers who wrote (10315)	7/1/1998 3:12:00 PM
From: VLAD	Read Replies (2) of 23519

betty, Thanks for your encouragement. The price of this stock is determined by the market makers and institutions. The logic behind current price is non existent. The market makers have driven the price so low now that the perception is that there is no future for Vivus. IMO this is the perception they want us to believe since they have already shaken out the small investors via margin calls or panic selling. Vivus will make a very good profit in Q3--in fact I really do believe that they will blow away earnings estimates regardless of US sales. China alone will bring in almost a dollar per share--and Vivus gets more for sales in China than regular overseas sales. With the money Vivus will make it will be able to buy back all its shares at $6.00. I feel sorry for the many small investors who got burned by the market manipulators. The comparissons made between Vivus and Pfizer are a sick joke at best. First I hear from the shorts that MUSE is too expensive--then we hear that Viagra sells for as much as $150.00/pill. Then we hear the bs about Vivus being a one drug company as compared to Pfizer but no comparrison is made about the number of shares that exist comparing the 2 companies. There are many many companies out there that sell only one product and one type of product--I can give countless examples but why bother. Betty, I have heard from reliable sources that Vivus may have difficulty keeping up with overseas demand for MUSE in Q3 regardless if US sales remain flat. I wish July 9th were here so we can be given the order numbers for Astra and Janssen. BTW Canada will approve MUSE this month--it will result in a Janssen milestone payment AND a lot of product being sent to Canada. These are very dark times for Vivus shareholders but there is light at the end of this tunnel.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next